Feeding gut microbes to nourish the brain: unravelling the diet–microbiota–gut–brain axis

E Schneider, KJ O'Riordan, G Clarke, JF Cryan - Nature metabolism, 2024‏ - nature.com
The prevalence of brain disorders, including stress-related neuropsychiatric disorders and
conditions with cognitive dysfunction, is rising. Poor dietary habits contribute substantially to …

Berberine pharmacology and the gut microbiota: A hidden therapeutic link

S Habtemariam - Pharmacological research, 2020‏ - Elsevier
Berberine is a natural pentacyclic isoquinoline alkaloid that has been isolated as the
principal component of many popular medicinal plants such as the genus Berberis, Coptis …

[HTML][HTML] Ketogenic diets alter the gut microbiome resulting in decreased intestinal Th17 cells

QY Ang, M Alexander, JC Newman, Y Tian, J Cai… - Cell, 2020‏ - cell.com
Very low-carbohydrate, high-fat ketogenic diets (KDs) induce a pronounced shift in
metabolic fuel utilization that elevates circulating ketone bodies; however, the …

[HTML][HTML] Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine

H Cheng, J Liu, Y Tan, W Feng, C Peng - Journal of pharmaceutical …, 2022‏ - Elsevier
Berberine (BBR), an isoquinoline alkaloid, has been found in many plants, such as Coptis
chinensis Franch and Phellodendron chinense Schneid. Although BBR has a wide spectrum …

A Review of Fibraurea tinctoria and Its Component, Berberine, as an Antidiabetic and Antioxidant

I Purwaningsih, IP Maksum, D Sumiarsa, S Sriwidodo - Molecules, 2023‏ - mdpi.com
Diabetes mellitus is a group of metabolic disorders characterized by hyperglycemia caused
by resistance to insulin action, inadequate insulin secretion, or excessive glucagon …

[HTML][HTML] Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

M Rizzo, A Colletti, PE Penson, N Katsiki… - Pharmacological …, 2023‏ - Elsevier
Abstract Non-Alcoholic Fatty Liver Disease (NAFLD) is a common condition affecting around
10–25% of the general adult population, 15% of children, and even> 50% of individuals who …